Surgeons Knowledge, Attitude, and Practice Toward Preoperative Inflammatory Bowel Disease Medications and Post-Operative Complications
Noura Alhassan,1 Abdullah Nasser Alnwdel,2 Mohammed Basem Beyari,3 Saleh Husam Aldeligan,3 Reem Alhassan,4 Maha Hamadien Abdulla,1 Thamer Bin Traiki1 1Colorectal Research Chair, Department of Surgery, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia; 2...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-07-01
|
| Series: | Therapeutics and Clinical Risk Management |
| Subjects: | |
| Online Access: | https://www.dovepress.com/surgeons-knowledge-attitude-and-practice-toward-preoperative-inflammat-peer-reviewed-fulltext-article-TCRM |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849732044707332096 |
|---|---|
| author | Alhassan N Alnwdel AN Beyari MB Aldeligan SH Alhassan R Abdulla MH Bin Traiki T |
| author_facet | Alhassan N Alnwdel AN Beyari MB Aldeligan SH Alhassan R Abdulla MH Bin Traiki T |
| author_sort | Alhassan N |
| collection | DOAJ |
| description | Noura Alhassan,1 Abdullah Nasser Alnwdel,2 Mohammed Basem Beyari,3 Saleh Husam Aldeligan,3 Reem Alhassan,4 Maha Hamadien Abdulla,1 Thamer Bin Traiki1 1Colorectal Research Chair, Department of Surgery, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia; 2Colorectal Surgery, Department of Surgery, King Fahad Specialist Hospital, Buraydah, Saudi Arabia; 3College of Medicine, King Saud University, Riyadh, Saudi Arabia; 4Pharmacy Department, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaCorrespondence: Mohammed Basem Beyari, Email Mohammedbeyari44@gmail.comBackground: Biologics, particularly anti-TNF agents, have transformed the management of inflammatory bowel disease (IBD), but concerns about their perioperative safety persist.Objective: This study evaluates the knowledge, attitudes, and practices of surgeons in Saudi Arabia regarding the preoperative management of IBD patients undergoing surgery while on biological treatments.Methods: A cross-sectional survey was conducted among 115 surgeons. Participants included general and colorectal surgeons with extensive experience in IBD management. Data were analyzed to assess knowledge, attitudes, and practices related to the impact of biologics, corticosteroids, and immunomodulators on wound healing and postoperative complications.Results: The response rate of 67.8% and Most surgeons (74.4%) believed biologics negatively affect wound healing, despite evidence suggesting their safety. Corticosteroids were unanimously recognized for their adverse effects, while immunomodulators were widely perceived as safe. A majority preferred tapering biologics and corticosteroids 4 weeks preoperatively but continued immunomodulators. Differences between specialties were observed, with colorectal surgeons demonstrating greater adherence to evidence-based guidelines compared to general surgeons, who expressed more concerns about biologics’ risks.Conclusion: This study identifies a persistent gap between evidence and practice in the perioperative management of IBD patients on biologics among Saudi surgeons, with general surgeons often stopping biologics due to safety concerns despite evidence of their safety, while colorectal surgeons are more likely to follow current guidelines. Unnecessary cessation may increase disease flare risk, highlighting the need for targeted education and multidisciplinary collaboration to optimize surgical outcomes.Keywords: inflammatory bowel disease, biologics, corticosteroids, immunomodulators, surgical outcomes |
| format | Article |
| id | doaj-art-e1f803058a5844d4bed5cda131e7c3a0 |
| institution | DOAJ |
| issn | 1178-203X |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Therapeutics and Clinical Risk Management |
| spelling | doaj-art-e1f803058a5844d4bed5cda131e7c3a02025-08-20T03:08:21ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2025-07-01Volume 21Issue 111491159105049Surgeons Knowledge, Attitude, and Practice Toward Preoperative Inflammatory Bowel Disease Medications and Post-Operative ComplicationsAlhassan N0Alnwdel AN1Beyari MB2Aldeligan SH3Alhassan R4Abdulla MH5Bin Traiki T6Department of SurgeryDepartment of SurgeryDepartment of surgeryCollege of MedicinePharmacy DepartmentDepartment of surgeryDepartment of SurgeryNoura Alhassan,1 Abdullah Nasser Alnwdel,2 Mohammed Basem Beyari,3 Saleh Husam Aldeligan,3 Reem Alhassan,4 Maha Hamadien Abdulla,1 Thamer Bin Traiki1 1Colorectal Research Chair, Department of Surgery, College of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia; 2Colorectal Surgery, Department of Surgery, King Fahad Specialist Hospital, Buraydah, Saudi Arabia; 3College of Medicine, King Saud University, Riyadh, Saudi Arabia; 4Pharmacy Department, Prince Sultan Military Medical City, Riyadh, Saudi ArabiaCorrespondence: Mohammed Basem Beyari, Email Mohammedbeyari44@gmail.comBackground: Biologics, particularly anti-TNF agents, have transformed the management of inflammatory bowel disease (IBD), but concerns about their perioperative safety persist.Objective: This study evaluates the knowledge, attitudes, and practices of surgeons in Saudi Arabia regarding the preoperative management of IBD patients undergoing surgery while on biological treatments.Methods: A cross-sectional survey was conducted among 115 surgeons. Participants included general and colorectal surgeons with extensive experience in IBD management. Data were analyzed to assess knowledge, attitudes, and practices related to the impact of biologics, corticosteroids, and immunomodulators on wound healing and postoperative complications.Results: The response rate of 67.8% and Most surgeons (74.4%) believed biologics negatively affect wound healing, despite evidence suggesting their safety. Corticosteroids were unanimously recognized for their adverse effects, while immunomodulators were widely perceived as safe. A majority preferred tapering biologics and corticosteroids 4 weeks preoperatively but continued immunomodulators. Differences between specialties were observed, with colorectal surgeons demonstrating greater adherence to evidence-based guidelines compared to general surgeons, who expressed more concerns about biologics’ risks.Conclusion: This study identifies a persistent gap between evidence and practice in the perioperative management of IBD patients on biologics among Saudi surgeons, with general surgeons often stopping biologics due to safety concerns despite evidence of their safety, while colorectal surgeons are more likely to follow current guidelines. Unnecessary cessation may increase disease flare risk, highlighting the need for targeted education and multidisciplinary collaboration to optimize surgical outcomes.Keywords: inflammatory bowel disease, biologics, corticosteroids, immunomodulators, surgical outcomeshttps://www.dovepress.com/surgeons-knowledge-attitude-and-practice-toward-preoperative-inflammat-peer-reviewed-fulltext-article-TCRMInflammatory bowel diseasebiologicscorticosteroidsimmunomodulatorssurgical outcomes |
| spellingShingle | Alhassan N Alnwdel AN Beyari MB Aldeligan SH Alhassan R Abdulla MH Bin Traiki T Surgeons Knowledge, Attitude, and Practice Toward Preoperative Inflammatory Bowel Disease Medications and Post-Operative Complications Therapeutics and Clinical Risk Management Inflammatory bowel disease biologics corticosteroids immunomodulators surgical outcomes |
| title | Surgeons Knowledge, Attitude, and Practice Toward Preoperative Inflammatory Bowel Disease Medications and Post-Operative Complications |
| title_full | Surgeons Knowledge, Attitude, and Practice Toward Preoperative Inflammatory Bowel Disease Medications and Post-Operative Complications |
| title_fullStr | Surgeons Knowledge, Attitude, and Practice Toward Preoperative Inflammatory Bowel Disease Medications and Post-Operative Complications |
| title_full_unstemmed | Surgeons Knowledge, Attitude, and Practice Toward Preoperative Inflammatory Bowel Disease Medications and Post-Operative Complications |
| title_short | Surgeons Knowledge, Attitude, and Practice Toward Preoperative Inflammatory Bowel Disease Medications and Post-Operative Complications |
| title_sort | surgeons knowledge attitude and practice toward preoperative inflammatory bowel disease medications and post operative complications |
| topic | Inflammatory bowel disease biologics corticosteroids immunomodulators surgical outcomes |
| url | https://www.dovepress.com/surgeons-knowledge-attitude-and-practice-toward-preoperative-inflammat-peer-reviewed-fulltext-article-TCRM |
| work_keys_str_mv | AT alhassann surgeonsknowledgeattitudeandpracticetowardpreoperativeinflammatoryboweldiseasemedicationsandpostoperativecomplications AT alnwdelan surgeonsknowledgeattitudeandpracticetowardpreoperativeinflammatoryboweldiseasemedicationsandpostoperativecomplications AT beyarimb surgeonsknowledgeattitudeandpracticetowardpreoperativeinflammatoryboweldiseasemedicationsandpostoperativecomplications AT aldeligansh surgeonsknowledgeattitudeandpracticetowardpreoperativeinflammatoryboweldiseasemedicationsandpostoperativecomplications AT alhassanr surgeonsknowledgeattitudeandpracticetowardpreoperativeinflammatoryboweldiseasemedicationsandpostoperativecomplications AT abdullamh surgeonsknowledgeattitudeandpracticetowardpreoperativeinflammatoryboweldiseasemedicationsandpostoperativecomplications AT bintraikit surgeonsknowledgeattitudeandpracticetowardpreoperativeinflammatoryboweldiseasemedicationsandpostoperativecomplications |